| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.06 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |